Refractory Marginal Zone Lymphoma Clinical Trials in Argenteuil, Île-de-France Region

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma